Unnamed pro-aging gene mRNA

The target 'Unnamed pro-aging gene mRNA' is a generic or placeholder designation for mRNA transcripts of genes that actively promote the biological aging process, often referred to as 'gerogenes' [2, 3]. These genes, such as CDKN2A (p16), KAT7, and ACBP/DBI, play critical roles in driving cellular senescence, chronic inflammation, and metabolic dysfunction [2, 3, 5]. Therapeutic intervention typically involves the use of antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), or CRISPR-based technologies to downregulate these transcripts and extend healthspan or lifespan [3, 11]. While no specific gene is officially named 'Unnamed,' the concept is central to the field of geroscience, where researchers aim to identify and inhibit drivers of age-related decline [11, 18]. Targeting these mRNAs offers a potential pathway to treat a broad spectrum of age-related conditions, including neurodegenerative diseases, cardiovascular disorders, and metabolic syndrome [2, 11]. However, the lack of a specific canonical name makes this entry technically incorrect or incomplete for precise therapeutic classification.

Other names

Pro-aging gene mRNAGerogene mRNASenescence-associated gene mRNA

Inhibition of pro-aging protein synthesis through mRNA degradation, translational repression, or gene silencing to prevent cellular senescence and age-related tissue decline.